Turkey / Abdi Ibrahim Buys 28.5% Stake in Swiss OM; A Historic Moment for Turkish Pharma
When Abdi Ibrahim acquired a 28.5 percent stake in Swiss biotech OM Pharma in September 2020, it represented a…
ARIS Turkey
Last updated: 13.02.2014
Address: ‘Eski Büyükdere Cad. Dilaver Sok. NO:4 34418
Oto Sanayi 4 Levent / İstanbul
,Turkey
Tel: +90 212 316 78 00
Web: http://www.aliraif.com.tr/
Company description
Ali Raif was founded under the name of Ali Raif ve Şeriki (Ali Raif and Associate) in 1928. Then company was reorganized in order to trade in pharmaceuticals industry by Muzaffer Turhan in 1963. Since 1983, the company has had operations under the name of Ali Raif Pharmaceutical Inc. Co.
Ali Raif was marketing pharmaceuticals as a licensee of multinational companies in the early years of its foundation. Then the company became one of the leading companies of the Turkish Pharmaceutical Industry starting to import finished pharmaceuticals and to produce and market generic pharmaceuticals.
After Ali Raif commenced generic pharmaceuticals licensing, producing and marketing, export opportunities started to arise in parallel to them. Export activities started with Azerbaijan and Georgia has enlarged with EU countries in 2003. Since 2005 they have speeded up greatly.
The countries that have been export are England, Portugal, Hungary, Azerbaijan, Georgia, The Philippines, Bulgaria, Spain, Algeria, and Poland.
Products and services
Ali Raif has nearly 150 pharmaceuticals with their forms in therapeutic fields such as cardiovascular, diabetics, gastrointestinal, analgesic, anti-inflammatory, anti-flu, antihistaminic, central nervous system.
Headquarters and production facilities are located in İkitelli, İstanbul, has totally 10 regional offices in Turkey.
Related
Company Spotlight / Acıbadem's Grand Ambitions
There is perhaps no Turkish company in the healthcare sector that is more ambitious than Acıbadem. Not only has…
Pharma Faces / Ferhat Farsi, Cinnagen
Dr Ferhat Farsi, CEO and founding partner of CinnaGen İlaç, shares his experience working for the largest biotech…
The Ideal Pharma Country Manager: Turkey (Stanton Chase)
Şükran Tümay, a senior partner at executive search and assessment firm Stanton Chase in Turkey, highlights the…
NEW Turkey Pharma Report Out Now!
Turkey – home to an 80 million-strong population, a substantial pharmaceuticals market and a universal healthcare…
Hospital Investments in Turkey: Bucking the Trend
Bucking a global trend for increased focus on outpatient and preventative care, Turkey is doubling down on…
Armağan Vurdu – General Secretary, IMMIB, Turkey
Armağan Vurdu, general secretary of the Istanbul Minerals and Metals Exporters Association (IMMIB) highlights the…
Ozlem Fidanci – CEO, Philips Middle East and Turkey
Ozlem Fidanci, CEO of the Middle East and Turkey at Philips, shares the collaborative approach Philips has…
Yelda Ulu Colin – General Manager, GE Healthcare Turkey
Yelda Ulu Colin, general manager of GE Healthcare in Turkey, offers her insider take on the country’s city…
Turkish Pharma: Eyeing Up Exports
Seizing the cost competitiveness of the Turkish market and the government’s nurturing of local manufacturing,…
Gamze Çıtıroğlu – General Manager; Murat Çıtıroğlu – Founder &…
Gamze Çıtıroğlu, Murat Çıtıroğlu and Pınar Çakır of Ekin Kimya discuss the progress of the Turkish…
Funda Gücer – Country Manager, Mylan Turkey
Funda Gücer, country manager at Mylan Turkey, portrays her experience in introducing the company to the Turkish…
